Congressional leaders’ proposal to keep the Food and Drug Administration operating for the rest of fiscal year 2024 instructs the agency to find $7m within its budget to reallocate to implementing its expanded regulatory toolkit for cosmetics.
A budget agreement reached by House and Senate leaders and a conference committee, which they published with their bill, HR...



